By Lauren Berg (July 22, 2022, 6:17 PM EDT) — A Delaware federal judge Thursday recommended denying a pair of biotech companies’ bids to toss Allergan Inc.’s lawsuit accusing them of infringing several of its patents related to its Botox brand botulinum toxin products….

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

• Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
• Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
• Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS